ABSTRACT - 595186 The disclosure relates to imidazole-pyrazolidinyl-carbamate derivatives represented by formula (I), wherein the variables are as defined in the specification. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.